Future Horizons and Growth Strategies in the European Cell Surface Marker Testing Market 2015: Supplier Shares and Country Forecasts
Complete report $3,850. DataPack (test volumes, sales forecasts, supplier shares) $2,500. The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country.
Rationale
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself. This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by country and market segment. The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 125 pages and 24 tables
Rationale
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself. This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by country and market segment. The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 125 pages and 24 tables
1. INTRODUCTION
2. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Lymphocyte Subclassification CD4/CD8/CD34
Instrumentation and Reagent Test Kits
BD
Beckman Coulter/Danaher
T Cells Diagnostics
B. CD34
C. Other Cell Markers
D. Instrumentation Review
1. Hematology Analyzers
a. Overview
Electrical Aperture Impedance Analyzers
Light Scatter Analyzers
b. System Review
Abbott
Beckman Coulter/Danaher
Biocode Hycel
Drew Scientific
Horiba
Menarini
Nihon Kohden
Siemens
Sysmex
2. FLOW CYTOMETERS
a. Introduction
b. System Overview
Becton Dickinson
Beckman Coulter/Danaher
E. Current Market Needs and Future Demand For Hematology Analyzers
F. Reagents and Controls
G. CURRENT AND EMERGING TECHNOLOGIES
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
3. FRANCE: FORECASTS BY TEST AND MARKET SEGMENT
4. GERMANY: FORECASTS BY TEST AND MARKET SEGMENT
5. ITALY: FORECASTS BY TEST AND MARKET SEGMENT
6. SPAIN: FORECASTS BY TEST AND MARKET SEGMENT
7. U.K.: FORECASTS BY TEST AND MARKET SEGMENT
8. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
9. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
10. COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Bio Rad
CellaVision
Horiba
Iris/Danaher
Nihon Kohden
Ortho Clinical Diagnostics
Roche
Siemens
Sysmex
11. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING HEMATOLOGY/FLOW CYTOMETRY TECHNOLOGIES AND APPLICATIONS
2. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Lymphocyte Subclassification CD4/CD8/CD34
Instrumentation and Reagent Test Kits
BD
Beckman Coulter/Danaher
T Cells Diagnostics
B. CD34
C. Other Cell Markers
D. Instrumentation Review
1. Hematology Analyzers
a. Overview
Electrical Aperture Impedance Analyzers
Light Scatter Analyzers
b. System Review
Abbott
Beckman Coulter/Danaher
Biocode Hycel
Drew Scientific
Horiba
Menarini
Nihon Kohden
Siemens
Sysmex
2. FLOW CYTOMETERS
a. Introduction
b. System Overview
Becton Dickinson
Beckman Coulter/Danaher
E. Current Market Needs and Future Demand For Hematology Analyzers
F. Reagents and Controls
G. CURRENT AND EMERGING TECHNOLOGIES
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
3. FRANCE: FORECASTS BY TEST AND MARKET SEGMENT
4. GERMANY: FORECASTS BY TEST AND MARKET SEGMENT
5. ITALY: FORECASTS BY TEST AND MARKET SEGMENT
6. SPAIN: FORECASTS BY TEST AND MARKET SEGMENT
7. U.K.: FORECASTS BY TEST AND MARKET SEGMENT
8. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
9. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
10. COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Bio Rad
CellaVision
Horiba
Iris/Danaher
Nihon Kohden
Ortho Clinical Diagnostics
Roche
Siemens
Sysmex
11. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING HEMATOLOGY/FLOW CYTOMETRY TECHNOLOGIES AND APPLICATIONS
LIST OF TABLES
France, Hospital Laboratories Estimated Cell Surface Marker Test Volume
France, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
France, Flow Cytometry Consumables Market By Major Supplier
France, Flow Cytometry Instrument Market By Major Supplier
France, Flow Cytometry Diagnostics Market By Major Supplier
Germany, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Germany, Flow Cytometry Consumables Market By Major Supplier
Germany, Flow Cytometry Instrument Market By Major Supplier
Germany, Flow Cytometry Diagnostics Market By Major Supplier
Italy, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Italy, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Italy, Flow Cytometry Consumables Market By Major Supplier
Italy, Flow Cytometry Instrument Market By Major Supplier
Italy, Flow Cytometry Diagnostics Market By Major Supplier
Spain, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Spain, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Spain, Ambulatory Care Center Estimated Cell Surface Marker Test Volume
Spain, Flow Cytometry Consumables Market By Major Supplier
Spain, Flow Cytometry Instrument Market By Major Supplier
Spain, Flow Cytometry Diagnostics Market By Major Supplier
U.K., Hospital Laboratories Estimated Cell Surface Marker Test Volume
U.K., Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
U.K., Flow Cytometry Consumables Market By Major Supplier
U.K., Flow Cytometry Instrument Market By Major Supplier
U.K., Flow Cytometry Diagnostics Market By Major Supplier
France, Hospital Laboratories Estimated Cell Surface Marker Test Volume
France, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
France, Flow Cytometry Consumables Market By Major Supplier
France, Flow Cytometry Instrument Market By Major Supplier
France, Flow Cytometry Diagnostics Market By Major Supplier
Germany, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Germany, Flow Cytometry Consumables Market By Major Supplier
Germany, Flow Cytometry Instrument Market By Major Supplier
Germany, Flow Cytometry Diagnostics Market By Major Supplier
Italy, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Italy, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Italy, Flow Cytometry Consumables Market By Major Supplier
Italy, Flow Cytometry Instrument Market By Major Supplier
Italy, Flow Cytometry Diagnostics Market By Major Supplier
Spain, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Spain, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Spain, Ambulatory Care Center Estimated Cell Surface Marker Test Volume
Spain, Flow Cytometry Consumables Market By Major Supplier
Spain, Flow Cytometry Instrument Market By Major Supplier
Spain, Flow Cytometry Diagnostics Market By Major Supplier
U.K., Hospital Laboratories Estimated Cell Surface Marker Test Volume
U.K., Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
U.K., Flow Cytometry Consumables Market By Major Supplier
U.K., Flow Cytometry Instrument Market By Major Supplier
U.K., Flow Cytometry Diagnostics Market By Major Supplier
